TGFB1 and diabetes mellitus: On comparison of the visceral depot, 42 gene sets were found to be upregulated in diabetics, of which 19 gene sets were significant at FDR < 25% including various immune system and inflammation-related pathways such as Interferon α, γ, Allograft rejection, IL-6 medicated JAK-STAT signaling, Complement activation, TGF-β signaling, and Inflammation.